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The recent development of new, sequencing-based molecular
tools for the accurate identiﬁcation of nontuberculous myco-
bacteria (NTM) recovered from clinical specimens has led to
the description of numerous new species over the past
10 years. Most of these new species comprise emerging,
opportunistic pathogens responsible for skin infection, surgical
site infection and respiratory tract infection. In particular,
these organisms have been recognized as being responsible
for respiratory tract infections in speciﬁc groups of patients,
such as cystic ﬁbrosis patients and patients with Lady Winder-
mere syndrome.
van Soolingen et al. detail, in this theme section, the sources
of these emerging mycobacteria. Although the precise source
remains unknown in most patients, these organisms have been
regularly isolated from water. The increasing number of
patients may, in part, mirror increasing contacts of populations
with man-modiﬁed water. Indeed, water-based technologies
have been extensively developed for several decades for use
in industry, interior decoration, leisure and body care, includ-
ing in beauty salons as well as clinics and hospitals.
These new forms of water use may not be as well-
controlled microbiologically as drinking water has been
controlled over the same period.
In such inanimate environments, NTM are in competition
with unicellular predators. Ben Salah et al. report on how
these organisms elaborated strategies to escape the
microbicidal mechanisms of unicellular phagocytes such as
free-living amoeba; these mechanisms are basically the same
as those used to further escape human macrophage microbi-
cidy, thus turning environmental organisms into opportunistic
pathogens.
The clinical consequences of infection as a result of these
emerging pathogens are reviewed by Tortoli who is credited
with discovering a number of these new species. The interpre-
tation of clinical laboratory data have to be based upon strict
criteria, such as those proposed by the American Thoracic
Society, in order to rightly attribute clinical disease to NTM.
In particular, the Mycobacterium mucogeninum group is
discussed.
This theme section devoted to emerging NTM is intended
to provide microbiologists, clinical microbiologists and infec-
tious diseases practitioners with keys to recognize these
organisms, beyond their position as mere contaminants, as
true opportunistic pathogens and to understand the unique
basis of their pathogenicity.
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